M Pfeilstöcker Selected Research

hemoregulatory peptide 5b

1/2001

Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Pfeilstöcker Research Topics

Disease

2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2001
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 05/2009
2	Iron Overload 05/2009 - 03/2008
1	Neoplasms (Cancer) 01/2021
1	Disease Progression 10/2020
1	Hematologic Diseases (Blood Diseases) 10/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2020
1	Hemolysis 10/2020
1	Cytopenia 01/2010
1	Refractory Anemia with Excess of Blasts (RAEM) 11/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2001
1	Lymphoma (Lymphomas) 07/2000

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2001 - 07/2000
1	eculizumab FDA Link 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	Ferritins (Ferritin)IBA 01/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2010
1	IronIBA 05/2009
1	Deferasirox FDA Link 05/2009
1	Pharmaceutical PreparationsIBA 03/2008
1	Chemokine CCL3IBA 01/2001
1	Peptides (Polypeptides)IBA 01/2001
1	hemoregulatory peptide 5bIBA 01/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2000
1	Surface Antigens (Surface Antigen)IBA 07/2000
1	Messenger RNA (mRNA)IBA 07/2000

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2020
1	Aftercare (After-Treatment) 11/2001
1	Salvage Therapy 07/2000
1	Drug Therapy (Chemotherapy) 07/2000